Cholesterol Guideline Row Highlights Doctor Conflicts
Prominent doctors who advised on cholesterol guidelines have ties to statin makers. Eight of nine panel members earned from drug companies, with two owning stock and two joining industry after guidance. Critics say industry links taint credibility while statins remain top selling drugs. The piece notes rising private funding of medical research and questions about independence in clinical advice.
MENTIONED IN THIS ARTICLE
Lipitor
Zocor
Scott Grundy
American Heart Association
Jerome Kassirer
New England Journal of Medicine
Christopher Seymour
National Lipid Association
America
Dr. X
Peoria
University of Ilinois
Frank Gold
Des Moines
Iowa
Ber
United States
Prosecutors say health complaints ignored for profit
San Diego case details Michael Ellis and Metabolife facing charges over Metabolite 356 diet pill. Prosecutors allege 14 000 health complaints from 1997 to 2002 including 18 heart attacks 26 strokes 43 seizures and five deaths were ignored as the firm grew. Ellis and Metabolife deny the accusations calling them baseless. A judge has dismissed some counts while others remain under review.
MENTIONED IN THIS ARTICLE
San Diego
Michael Ellis
Metabolite International Inc
Ellis
Life 356
Company
US Food and Drug Administration
Metabolite
Associated Press
Jan Strode
Statins Dominate Cholesterol Fight Across Nations
Statins such as Mevacor Lipitor and Zocor are widely used to lower cholesterol and prevent heart attacks. The U S and Britain have seen growing use with some calls for over the counter availability and lower target levels, though questions linger about potential pharmaceutical funding influence on guidance.
MENTIONED IN THIS ARTICLE
Britain
United States
U.S
Also Mentioned on This Page
Tufts University School of Medicine
Boston
Kassirer
Metabolife Company
The
McCreless Company
N. Grant
Odessa
McCrelesscompany.com
Kay
Ce Ge Oh
Exas Tech
4Th St
Mec Media
Center Kopital
Ame
Fafan